KASAHARA Toshihiko | Pharmaceutical Research Center
スポンサーリンク
概要
関連著者
-
KASAHARA Toshihiko
Pharmaceutical Research Center
-
Kasahara Toshihiko
Department Of Molecular Toxicology And The 21st Century Coe Program School Of Pharmaceutical Science
-
Hashiba Masamichi
Department Of Molecular Toxicology And The 21st Century Coe Program School Of Pharmaceutical Science
-
Harada Tsuyoshi
Development Research Mochida Pharmaceutical Co. Ltd.
-
Degawa Masakuni
Department Of Molecular Toxicology And The 21st Century Coe Program School Of Pharmaceutical Science
-
DEGAWA Masakuni
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
KASAHARA Toshihiko
Department of Molecular Toxicology and COE Program in the 21st Century, School of Pharmaceutical Sci
-
HASHIBA Masamichi
Department of Molecular Toxicology and COE Program in the 21st Century, School of Pharmaceutical Sci
-
柿沼 千早
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Kuwayama Chitose
Department Of Pathology Juntendo University School Of Medicine
-
桑山 知登世
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Kasahara Toshihiko
Department Of Applied Biochemistry Hiroshima University
-
Kakinuma Chihaya
Pharmaceutical Research Center
-
Degawa Masakuni
Department Of Hygienic Chemistry Faculty Of Pharmaceutical Sciences Tohoku University
-
Kuwayama Chitose
Pharmaceutical Research Center Mochida Pharmaceutical Co. Ltd
-
柿沼 千早
Department of Pathology, Juntendo University, School of Medicine
-
OGIHARA Takuo
Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd.
-
OHNISHI Shuhei
Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd.
-
OZAWA Makoto
Pharmaceutical Research Center
-
MURANO Hiroyuki
Research Planning and Management, Mochida Pharmaceutical Co., Ltd.
-
OHNIHSI Shuhei
Pharmaceutical Research Center
-
KUWAYAMA Chitose
Department of Pathology, Juntendo University School of Medicine
-
HARADA Tsuyoshi
First Department of Biochemistry, Saitama Medical School
-
KAKINUMA Chihaya
Department of Pathology, Juntendo University School of Medicine
-
HARADA Tsuyoshi
Toxicology Laboratory, Mochida Pharmaceutical Co., Ltd.
-
HASHIBA Masamichi
Toxicology Laboratory, Mochida Pharmaceutical Co., Ltd.
-
OBATA Masaomi
Toxicology Laboratory, Mochida Pharmaceutical Co., Ltd.
-
KASAHARA Toshihiko
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Ogihara Takuo
Pharmaceutical Research Center Mochida Pharmaceutical Co. Ltd.
-
Obata Masaomi
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Obata Masaomi
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Ohnishi Shuhei
Pharmaceutical Research Center Mochida Pharmaceutical Co. Ltd.
-
Kasahara Toshihiko
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Ogihara Takuo
Pharmaceutical Research Center
-
Murano Hiroyuki
Research Planning And Management Mochida Pharmaceutical Co. Ltd.
-
Harada Tsuyoshi
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Miyauchi Makoto
Department Of Pathology Juntendo University School Of Medicine
-
Miyauchi Makoto
Pharmaceutical Research Center
-
TOMITA Kazuo
Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd.
-
KAKINUMA Chihaya
Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd.
-
HAMADA YOSHIMASA
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
Tomita Kazuo
Pharmaceutical Research Center
-
HARADA Tsuyoshi
Development Research, Mochida Pharmaceutical Co., Ltd.
-
DEGAWA MASAKUNI
School of Pharmaceutical Sciences, University of Shizuoka
-
Ohnishi Shuhei
Pharmaceutical Research Center
-
KIM Sung
Laboratory of Chemical Biology, Department of Pharmacological Sciences, State University of New York
-
SHIBUTANI Shinya
Laboratory of Chemical Biology, Department of Pharmacological Sciences, State University of New York
-
HASHIBA Masamichi
School of Pharmaceutical Sciences, University of Shizuoka
-
KASAHARA Toshihiko
School of Pharmaceutical Sciences, University of Shizuoka
-
OCHIAI Toshiaki
Toxicology Laboratory, Research Center, Mochida Pharmaceutical Co., Ltd.
-
Kim Sung
Laboratory Of Chemical Biology Department Of Pharmacological Sciences State University Of New York A
-
Ochiai Toshiaki
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Ochiai Toshiaki
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Degawa Masakuni
School Of Pharmaceutical Sciences University Of Shizuoka
-
Hamada Yoshimasa
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Hamada Yoshimasa
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Shibutani Shinya
Laboratory Of Chemical Biology Department Of Pharmacological Sciences State University Of New York A
-
Shibutani Shinya
Laboratory Of Chemical Biology Department Of Pharmacological Sciences State University Of New York A
著作論文
- Efficiency of toxicological screening at the drug-discovery stage (1) Comparison of various cell lines and methods on cytotoxicity(Cytotoxicity, Proceedings of the 32nd Annual Meeting)
- The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis
- Efficiency of toxicological screening at drug-discovery stage (2) Establishment of high-throughput screening system for detection of phospholipidosis(Test methods, Proceedings of the 32nd Annual Meeting)
- DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver
- Difference between tamoxifen and toremifene in hepatocarcinogenic activity toward female rats : Study on the gene expression of hepatic proteins responsible for DNA repair and cell proliferation(Mutagenicity, Carcinogenicity, Proceedings of the 32nd Annua
- Increased Expression of Cyclin-Dependent Kinase-Interacting Protein p21 during Tamoxifen-Induced Hepatocarcinogenesis in Female Rats
- P-12 Application of RT-PCR for analysis of hepatic drugmetabolizing enzyme induction in rats treated with tamoxifen.(Proceedings of the 27th Annual Meeting)
- O-34 Reverse transcription polymerase reaction (RTPCR) analysis of proto-oncogene expression induced by tamoxifen in rat liver.(Proceedings of the 27th Annual Meeting)